IBRX 241220 1.50C (IBRX241220C1500) Stock Options, News & Quotes

US OptionsDetailed Quotes

IBRX241220C1500

Watchlist

3.46
0.000.00%

15min DelayClose Dec 13 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Express News | D. Boral Capital Served as Co-Manager to Immunitybio, Inc. (Nasdaq: Ibrx) in Connection With Its $100.0 Million Underwritten Public Offering
ReutersDec 12 08:00 ET
ImmunityBio Shares Slide 33% After Public Offering Prices
WSJDec 11 14:49 ET · Movers
What's Going On With ImmunityBio Shares Wednesday?
BenzingaDec 11 11:06 ET
US Consumer Prices Rise in Line With Expectations in November as US Equity Futures Rise Pre-Bell
MT NewswiresDec 11 09:03 ET
Macy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
BenzingaDec 11 08:46 ET
Top Premarket Decliners
MT NewswiresDec 11 07:49 ET

Comments

LilMissDiamondNips

9 hours ago

$ImmunityBio (IBRX.US)$ wheres what's his fuck that posts everyday his % percentages.

Moomoo Recap US

Dec 11 15:29

Columns Nasdaq Surges Past 20,000 for the First Time, Powered by Tech Giants | Wall Street Today

The $Nasdaq Composite Index (.IXIC.US)$ hit a record intraday and closing high Wednesday, crossing 20,000 points for the first time. The index was up 1.8% at 20,050 in late trading, finishing 1.77% higher. The $S&P 500 Index (.SPX.US)$ closed just below its highest close on record at 6,090.27, while the $Dow Jones Industrial Average (.DJI.US)$ fell 0.2%.
MACRO
In economic news, November’s consumer price index (C...

$ImmunityBio (IBRX.US)$

Stock_Drift

Nov 21 09:10

$ImmunityBio (IBRX.US)$

Trytosaveabit

Nov 19 13:31

Update

$ImmunityBio (IBRX.US)$ ImmunityBio Completes ANKTIVA's Post-Approval Enrollment Of The 100th Patient In BCG Unresponsive NMIBC CIS Trial And Reports A Complete Response Rate Of 71% With A Durable Duration Of Response Ranging Up To 54 Months Reported For 82 Patients Published In NEJM
High responder rate associated with a duration of response ranging as long as 54 months in QUILT-3.032 with 100 patients enrolledUpdated data intended to be submitted as part of a European Medicines Agency (EMA...